Literature DB >> 1339398

Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester.

B A Perry1, H W Mohrenweiser.   

Abstract

Denaturing gradient gel electrophoreses of polymerase chain reaction amplified DNA products and subsequent direct sequencing identified a G-to-A transition causing a replacement of Gly 122 with Arg in an electrophoretic mobility variant of human triosephosphate isomerase, TPI-Manchester. This was the only TPI electromorph variant detected in screening of greater than 3,400 humans in an Ann Arbor, Mich. population. This substitution is at the amino terminus or solvent interaction end of the fifth beta sheet of the alpha/beta barrel structure. The TPI-Manchester variant is a thermolabile enzyme, but the stability of the variant enzyme is not sensitive to other denaturants. This amino acid substitution does not involve residues of the active site and does not detectably alter the kinetic properties of the enzyme. The data provide additional insight into the amino acid residues that are important for the maintenance of the structural characteristics of this very evolutionary constrained protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339398     DOI: 10.1007/bf02265287

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Structure of yeast triosephosphate isomerase at 1.9-A resolution.

Authors:  E Lolis; T Alber; R C Davenport; D Rose; F C Hartman; G A Petsko
Journal:  Biochemistry       Date:  1990-07-17       Impact factor: 3.162

2.  Human triosephosphate isomerase cDNA and protein structure. Studies of triosephosphate isomerase deficiency in man.

Authors:  L E Maquat; R Chilcote; P M Ryan
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

3.  Detection of single base substitutions in total genomic DNA.

Authors:  R M Myers; N Lumelsky; L S Lerman; T Maniatis
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

4.  Proton diffusion in the active site of triosephosphate isomerase.

Authors:  I A Rose; W J Fung; J V Warms
Journal:  Biochemistry       Date:  1990-05-08       Impact factor: 3.162

5.  Cell proliferation-associated expression of a recently evolved isozyme of triosephosphate isomerase.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1985-04       Impact factor: 1.890

6.  Subunit interface of triosephosphate isomerase: site-directed mutagenesis and characterization of the altered enzyme.

Authors:  J I Casal; T J Ahern; R C Davenport; G A Petsko; A M Klibanov
Journal:  Biochemistry       Date:  1987-03-10       Impact factor: 3.162

7.  Functional hemizygosity in the human genome: direct estimate from twelve erythrocyte enzyme loci.

Authors:  H W Mohrenweiser
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

8.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

9.  Origin of the triosephosphate isomerase isozymes in humans: genetic evidence for the expression of a single structural locus.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

10.  Chicken triosephosphate isomerase complements an Escherichia coli deficiency.

Authors:  D Straus; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  6 in total

1.  Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus.

Authors:  M Watanabe; B C Zingg; H W Mohrenweiser
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

2.  Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme.

Authors:  S C Mande; V Mainfroid; K H Kalk; K Goraj; J A Martial; W G Hol
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

3.  Human triosephosphate isomerase deficiency resulting from mutation of Phe-240.

Authors:  M L Chang; P J Artymiuk; X Wu; S Hollán; A Lammi; L E Maquat
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

4.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

5.  Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.

Authors:  R Pieper; R E Christian; M I Gonzales; M I Nishimura; G Gupta; R E Settlage; J Shabanowitz; S A Rosenberg; D F Hunt; S L Topalian
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

Review 6.  Protein crystallography and infectious diseases.

Authors:  C L Verlinde; E A Merritt; F Van den Akker; H Kim; I Feil; L F Delboni; S C Mande; S Sarfaty; P H Petra; W G Hol
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.